Are clinical trial costs covered?

Under federal law (ACA § 2709), health insurers generally cover routine patient care costs in approved trials. Review the trial Informed Consent Form for specific sponsor-funded items.

7 Recruiting Multiple Myeloma Clinical Trials

Q: How do I qualify for a Multiple Myeloma clinical trial?

Qualification depends on diagnostic staging, previous treatment history, and study-specific inclusion criteria. Use our preliminary self-screener on any study page to evaluate basic criteria.

Explore open interventional and observational research studies actively enrolling participants across the USA.

📍 Find Near Me with Distance Radius

Not Applicable 📊 Observational Clinical Research

NCT03717844

Registry for Adults With Plasma Cell Disorders (PCD's)

📍 North Carolina Cancer Hospital — Chapel Hill, North Carolina

View Study & Screener ➔

Phase 3 💊 Investigational Drug / Biologic

NCT06980480

A Study of Gammagard Liquid (Immune Globulin Infusion, 10%) to Prevent Infections in Adults With Multiple Myeloma

📍 Infirmary Health - Diagnostic & Medical Clinic (DMC) — Mobile, Alabama

View Study & Screener ➔

Phase 2 💊 Investigational Drug / Biologic

NCT06940297

Dasatinib and Quercetin With CAR-T Therapy for the Treatment of Patients With Relapsed or Refractory Multiple Myeloma

📍 Mayo Clinic in Rochester — Rochester, Minnesota

View Study & Screener ➔

Phase 2 💊 Investigational Drug / Biologic

NCT06500884

A Study to Evaluate Preventive Treatments for GPRC5D-related Oral Events

📍 University of California San Francisco — San Francisco, California

View Study & Screener ➔

Not Applicable 📊 Observational Clinical Research

NCT07225738

A Multicenter Prospective Observational Cohort Study Evaluating the Impact of Cancer-Directed Treatment and Medication Use, Including Cannabis Use, in Multiple Myeloma Patients

📍 CTCA at Western Regional Medical Center — Goodyear, Arizona

View Study & Screener ➔

Phase 2 💊 Investigational Drug / Biologic

NCT06100237

Teclistamab in Combination With Daratumumab for High-Risk Smoldering Myeloma: A Clinical and Correlative Phase 2 Immuno-Oncology Study (the REVIVE Study)

📍 University of Miami — Miami, Florida

View Study & Screener ➔

Phase 3 💊 Investigational Drug / Biologic

NCT07285239

Belantamab Mafodotin or Daratumumab With Bortezomib, Lenalidomide and Dexamethasone for Newly Diagnosed Multiple Myeloma

📍 Gundersen Lutheran — La Crosse, Wisconsin

View Study & Screener ➔

Frequently Asked Questions: Multiple Myeloma Clinical Trials

How do I qualify for a Multiple Myeloma clinical trial?

Qualification depends on diagnostic staging, prior therapies, and health stability. Use our preliminary self-screener on individual study pages.

Are trial treatments covered by insurance?

Under federal ACA § 2709, routine patient care costs are covered by health insurance. Review the study Informed Consent document with your doctor for details.